Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal triamcinolone injection for chronic rhinosinusitis with nasal polyps
IRCT20130812014333N256Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of triamcinolone in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Rate of recovery. Started Jul 2025; status: completed.
02
Drugs
triamcinolone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20130812014333N256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N256.